Some Confidence Is Lacking In Krystal Biotech, Inc.'s (NASDAQ:KRYS) P/S
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
Unusual Options Activity: C, DAL and Others Attract Market Bets, C V/OI Ratio Reaches 519.3
EST Nov 6th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction
Krystal Biotech Is Maintained at Neutral by Citigroup